Navigation Links
IGY Immune Technology & Life Sciences Purchases Manufacturing Facility to Produce Purified Immunoglobulin Y (IgY)
Date:4/30/2012

THUNDER BAY, Ontario, April 30, 2012 /PRNewswire/ -- IGY Immune Technology & Life Sciences has acquired manufacturing capabilities to produce its proprietary IgY products.  IgY from chicken egg yolks has long been recognized among scientists for its immune enhancing benefits in humans as well as its ability to deliver customized antibodies to fight sickness and maintain good health.  Until now, a consistent, purified source has not been available commercially.  IGY Immune Technology & Life Sciences expects to be producing IgY by the end of 2012.

"The acquisition of this facility and our existing intellectual property position make IGY Immune Technology the world's leader in the production of IgY," said Terry Dyck, chief executive officer. "The production of IgY at higher purity levels and lower cost will create a number of product development opportunities across the nutrition, cosmetic, pharmaceutical and animal health industries."

The existing world supply of IgY is very limited and expensive.  IGY Immune Technology's unique process is able to produce commercial quantities of IgY from chicken egg yolk.  The manufacturing facility is in close proximity to major egg producers and the production process utilizes no toxic chemicals allowing the egg yolk to be returned back into the food supply.

IGY Immune Technology & Life Sciences is already in the commercialization process with its first product and has a number of business partnerships in development with major life sciences corporations.  An opportunity for investment in IGY Immune Technology is also available.

"We're establishing ourselves already with leading companies that have been following IgY developments," said Dyck.  "We're moving forward in securing these partnerships as well as providing a profitable opportunity for investors."

For more information about IGY Immune Technology & Life Sciences, visit its web site at: http://www.igylifesciences.com


'/>"/>
SOURCE IGY Immune Technology & Life Sciences
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Discovery in Nature elucidates immune cells in skin and supports novel vaccine approach
2. Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC)
3. MU researchers identify key plant immune response in fight against bacteria
4. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
5. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
6. Immune Design Corp. and Sanofi-Aventis Announce Research Collaboration
7. Immune Design Corp. Appoints Guy F. Cipriani as Chief Business Officer
8. Alcohol-related behavior changes -- blame your immune system
9. Immune Deficiency Foundation Launches Free Accredited Course for Nurses About Primary Immunodeficiency and Immunoglobulin Therapy
10. New HIV vaccine approach targets desirable immune cells
11. David H. Murdock Research Institute Assumes Control of the Immune Tolerance Institute and Establishes a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... On Wednesday, June 22, 2016, the NASDAQ Composite ... Jones Industrial Average edged 0.27% lower to finish at 17,780.83; ... has initiated coverage on the following equities: Infinity Pharmaceuticals Inc. ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ), ... more about these stocks by accessing their free trade alerts ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. ... a free webinar on Performing Quality Investigations: Getting to Root Cause. ... at no charge. , Incomplete investigations are still a major concern to the ...
(Date:6/23/2016)... 2016  Amgen (NASDAQ: AMGN ) today ... life sciences incubator to accelerate the development of ... space at QB3@953 was created to help high-potential life ... many early stage organizations - access to laboratory infrastructure. ... launched two "Amgen Golden Ticket" awards, providing each winner ...
(Date:6/22/2016)... , June 22, 2016 Cell Applications, ... allow them to produce up to one billion ... lot within one week. These high-quality, consistent stem ... preparing cells and spend more time doing meaningful, ... a proprietary, high-volume manufacturing process that produces affordable, ...
Breaking Biology Technology:
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
Breaking Biology News(10 mins):